https://doi.org/10.4081/aiua.2014.4.314

Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance

Vol. 86 No. 4 (2014)
Submitted: January 23, 2015
Accepted: January 23, 2015
Published: December 30, 2014
Prostate cancer, Prostate biopsy, Active surveillance, Tumour extent, Immunohistochemistry
Abstract Views: 1552
PDF: 725
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Roberta Mazzucchelli
Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.
Andrea Benedetto Galosi
Division of Urology, “Augusto Murri” General Hospital, ASUR Marche, Fermo, Italy.
Antonio Lopez-Beltran
Department of Surgery, Cordoba University Medical School, Cordoba, Spain.
Marina Scarpelli
Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.
Liang Cheng
Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Rodolfo Montironi
r.montironi@univpm.it
Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.
Active surveillance (AS) is an important management option for men with lowrisk, clinically localized prostate cancer. The clinical parameters for patient selection and definition of progression for AS protocols are evolving as data from several large cohorts become mature. Vital to this process is the critical role pathologic parameters play in identifying appropriate candidates for AS. These findings need to be reproducible and accurately reported by pathologists. Repeated biopsy after initial diagnosis of prostate cancer is recommended before inclusion in active surveillance for early detection of significant cancer.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Mazzucchelli, R., Galosi, A. B., Lopez-Beltran, A., Scarpelli, M., Cheng, L., & Montironi, R. (2014). Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance. Archivio Italiano Di Urologia E Andrologia, 86(4), 314–318. https://doi.org/10.4081/aiua.2014.4.314

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.